XingImaging Launches Advanced Research Facility
XingImaging, part of the MITRO group, is thrilled to reveal the opening of its cutting-edge research facility. This latest development signifies a major step forward in their ongoing commitment to pioneering advancements in the field of imaging and radiopharmaceutical services.
Facility Features and Focus
The new facility is equipped with top-of-the-line technologies, including a clinic tailored for recruiting and evaluating clinical research participants. It boasts a range of sophisticated equipment such as cGMP radiochemistry laboratories, as well as PET-CT and SPECT-CT scanners, all designed to enhance imaging capabilities.
Advanced Imaging Technology
This technology includes the highly regarded NeuroExplorer PET scanner from United Imaging, renowned for its ultra-high performance in studying brain function. This unique PET scanner is set to advance the analysis of neurodegenerative diseases like Parkinson's and Alzheimer's, offering outstanding resolution and sensitivity.
Contributions to Research Community
With this state-of-the-art facility, XingImaging is poised to make significant contributions to the research community. The emphasis on quality underpins every aspect of their operation, from radiotracer manufacturing to the careful analysis of clinical imaging data.
Commitment to Excellence
CEO Gilles Tamagnan expressed enthusiasm about the launch, highlighting New Haven's role as a hub for innovation in research and healthcare. "This facility embodies our mission to deliver top-notch imaging solutions and to accelerate life-saving treatment development," he stated.
Service Offerings
The facility will provide a wide range of services, including:
Clinical Trial Services: This includes comprehensive support for research participants in clinical trials, ensuring a compassionate and effective experience.
Advanced Imaging Services: Offering cutting-edge imaging technology with a strong focus on precision, particularly through PET and SPECT.
Radiotracer Manufacturing: A personalized approach to GMP production tailored precisely to clinical trial needs with rigorous quality control measures.
Imaging Analysis Services: Customized analysis solutions aimed at enhancing signal-to-noise ratios and ensuring robustness and reproducibility in results.
XingImaging demonstrates an unwavering commitment to excellence throughout this facility’s operations, promising high-quality service for participants, sponsors, and collaborators alike.
About XingImaging
XingImaging stands as a leader in the domain of advanced imaging and radiopharmaceutical services. Their dedication to quality and innovation manifests in their ability to offer an all-encompassing suite of clinical trial imaging services collaborated with pharmaceutical and biotech organizations to get advancements in medical diagnostics.
About MITRO
MITRO is a molecular imaging contract research organization based in China. Known for its high-quality contract research services for drug development, MITRO employs radiolabeling and molecular imaging techniques. With the merger between MITRO and XingImaging, both entities have combined forces to deliver extensive CRO and CDMO service offerings.
Frequently Asked Questions
What services does XingImaging provide?
XingImaging offers a range of services including advanced imaging, clinical trial support, radiotracer manufacturing, and analytical services tailored for drug development and research.
Where is the new facility located?
The new XingImaging research facility is located in New Haven, Connecticut, focusing on innovative medical diagnostics.
What technologies are featured at the new facility?
The facility features advanced imaging technologies, including the NeuroExplorer PET scanner, as well as state-of-the-art radiochemistry laboratories.
Who is the CEO of XingImaging?
Gilles Tamagnan serves as the CEO of XingImaging and has emphasized the company's commitment to quality and innovation in imaging services.
What impact does this facility have on research?
This facility enhances XingImaging's ability to support scientific research endeavors through improved imaging technologies and comprehensive service offerings for clinical trials.
